L&G Pharma Breakthrough UCITS ETF (ETR:ETLI)
9.22
+0.07 (0.72%)
Jul 3, 2025, 1:12 PM CET
ETR:ETLI Holdings List
As of Jun 30, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | HKG: 9969 | InnoCare Pharma Limited | 3.79% |
2 | AMS: PHARM | Pharming Group N.V. | 3.71% |
3 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.70% |
4 | BCRX | BioCryst Pharmaceuticals, Inc. | 3.41% |
5 | IONS | Ionis Pharmaceuticals, Inc. | 3.30% |
6 | TYO: 4151 | Kyowa Kirin Co., Ltd. | 3.14% |
7 | ZVRA | Zevra Therapeutics, Inc. | 3.12% |
8 | XERS | Xeris Biopharma Holdings, Inc. | 3.11% |
9 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 3.09% |
10 | RPRX | Royalty Pharma plc | 3.05% |
11 | NVSN.MX | Novartis AG ADR | 2.91% |
12 | STO: SOBI | Swedish Orphan Biovitrum AB (publ) | 2.87% |
13 | EPA: IPN | Ipsen S.A. | 2.82% |
14 | LGND | Ligand Pharmaceuticals Incorporated | 2.79% |
15 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.78% |
16 | TYO: 4523 | Eisai Co., Ltd. | 2.75% |
17 | ONC | BeOne Medicines Ltd. | 2.74% |
18 | INCY | Incyte Corporation | 2.71% |
19 | PTCT | PTC Therapeutics, Inc. | 2.66% |
20 | TYO: 4188 | Mitsubishi Chemical Group Corporation | 2.66% |
21 | RARE | Ultragenyx Pharmaceutical Inc. | 2.65% |
22 | JNJ | Johnson & Johnson | 2.56% |
23 | VRTX | Vertex Pharmaceuticals Incorporated | 2.53% |
24 | AZN | AstraZeneca PLC | 2.53% |
25 | UTHR | United Therapeutics Corporation | 2.52% |
26 | BME: PHM | Pharma Mar, S.A. | 2.52% |
27 | KRX: 051910 | LG Chem, Ltd. | 2.50% |
28 | HALO | Halozyme Therapeutics, Inc. | 2.40% |
29 | AMGN | Amgen Inc. | 2.39% |
30 | CPH: GMAB | Genmab A/S | 2.39% |
31 | BIIB | Biogen Inc. | 2.35% |
32 | TVTX | Travere Therapeutics, Inc. | 2.29% |
33 | TYO: 4516 | Nippon Shinyaku Co., Ltd. | 2.23% |
34 | JAZZ | Jazz Pharmaceuticals plc | 2.16% |
35 | BMRN | BioMarin Pharmaceutical Inc. | 2.14% |
36 | BMY | Bristol-Myers Squibb Company | 2.13% |
37 | SRPT | Sarepta Therapeutics, Inc. | 0.47% |
38 | n/a | Cash | 0.10% |
39 | n/a | Euro | 0.03% |
40 | n/a | Danish Krone | 0.01% |
As of Jun 30, 2025